Table 4 Scores for the EORTC QLQ-C30 and BLM-30, presented as median (min–max)
|  | Preoperative (n = 8) | At discharge (n = 8) | 4-month follow-up (n = 4) |
|---|---|---|---|
QLQ-C30 | |||
Global quality of life scalea | 79 (0–92) | 33 (0–83) | 92 (67–100) |
Functional scalesa | |||
 Physical functioning | 87 (67–100) | 43 (0–67) | 90 (67–93) |
 Role functioning | 100 (50–100) | 25 (0–100) | 100 (83–100) |
 Emotional functioning | 82 (17–100) | 75 (33–100) | 92 (75–100) |
 Cognitive functioning | 83 (3–100) | 67 (17–100) | 75 (50–100) |
 Social functioning | 75 (0–100) | 42 (0–83) | 100 (67–100) |
Symptom scales | |||
 Fatigue | 38 (0–67) | 90 (23–100) | 28 (0–33) |
 Nausea/Vomiting | 0 (0–17) | 33 (17–100) | 0 (0–0) |
 Pain | 9 (0–67) | 75 (0–100) | 0 (0–0) |
 Dyspnoea | 17 (0–33) | 50 (0–100) | 33 (33–67) |
 Insomnia | 33 (0–100) | 67 (33–100) | 0 (0–0) |
 Appetite loss | 0 (0–100) | 84 (33–100) | 0 (0–0) |
 Constipation | 0 (0–33) | 50 (0–100) | 17 (0–33) |
 Diarrhoea | 0 (0–100) | 17 (0–67) | 0 (0–0) |
 Financial difficulties | 0 (0–67) | 0 (0–67) | 0 (0–0) |
BLM-30 | |||
 Urinary symptoms | 58 (0–87) | 0 (0–3) (n = 3) | 23 (3–43) (n = 2) |
 Urostomy problems |  | 10 (0–27) (n = 5) | 23 (3–43) (n = 2) |
 Future perspective | 28 (10–100) | 23 (0–67) | 0 (0–23) |
 Abdominal bloating and flatulence | 9 (0–67) | 67 (0–100) | 0 (0–0) |
 Body Image | 17 (0–67) | 33 (10–100) | 5 (0–23) |
 Sexual functioning, last four weeks, (n = 6) | 42 (0–100) | 100 (0–100) | 100 (0–100) |
 Sexual life, last four weeksa | 17 (0–33) | 0 (0–17) | 9 (0–17) |